Skip to main content
Clinical Trials/ISRCTN97009661
ISRCTN97009661
Completed
未知

Evaluating the feasibility, suitability and potential efficiency of Cannabis Sativa oil on pain and quality of life assessment for patients with burning mouth syndrome: a prospective open-label single-arm pilot study

niversity of Turin0 sites17 target enrollmentMay 6, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Burning mouth syndrome
Sponsor
niversity of Turin
Enrollment
17
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/33123730/ (added 02/12/2020)

Registry
who.int
Start Date
May 6, 2020
End Date
May 1, 2020
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Turin

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \= 18
  • 2\. Burning mouth syndrome diagnosis
  • 3\. No detectable oral mucosal lesions
  • 4\. Able to complete the present clinical trial

Exclusion Criteria

  • 1\. Unable or unwilling to provide informed consent
  • 2\. Significant psychiatric or cognitive impairment
  • 3\. Other diagnoses that could explain the neuropathic pain
  • 4\. Diagnosis of Sjögren Syndrome on the basis of AECG criteria
  • 5\. Previous head and neck radiotherapy
  • 6\. Diagnosed lymphoma
  • 7\. Hepatitis C infection
  • 8\. Pregnant or breast\-feeding women

Outcomes

Primary Outcomes

Not specified

Similar Trials